A system hybridizing cardiac contractility modulation and implantable cardioverter defibrillation successfully converted ...

Tim Boreham sharpens his knifes to look under the hood at cardiac pacing device innovator EBR Systems after its US FDA ...

Despite the positive results, there are open questions about LBB pacing, including long-term lead performance. RCTs are ...

Over half of the patients improved by at least one New York Heart Association (NYHA) class, and another 40% remained stable. The device operates by syncing with existing pacemakers, ICDs, or CRT ...

Empowering Physicians, Powering Hearts. "We're delighted for the heart failure patients who were not treatable with existing CRT lead-based devices," said John McCutcheon, President and CEO of EBR ...

Medtronic plc has received U.S. Food and Drug Administration (FDA) approval for the OmniaSecure defibrillation lead for ...

Medtronic receives US FDA approval for smallest-diameter, lumenless defibrillation lead, the OmniaSecure lead: Galway, ...

The choice between ICD types still should be based on each individual patient’s risk factors, Kenneth Ellenbogen says.

The device tackles the age-old problem of accessing the left ventricle for cardiac resynchronisation therapy (CRT). CRT is a subset of the cardiac rhythm management sector that includes ...